Screening for spina bifida cystica. A cost-benefit analysis.

AUTOR(ES)

Hagard, S

RESUMO

The costs and economic benefits are examined of introducing a programme for the mass-screening of pregnancies for the detection and abortion of fetuses with spina bifida cystica. A benefit-cost index is derived, and the possible effects on it of making different input assumptions are discussed. It is considered that, on economic grounds, screening may be worthwhile only in populations in which the incidence of spina bifida is high.

Documentos Relacionados

• A Cost-Benefit Analysis of California's Mandatory Premarital Screening Program for Syphilis
• Cost-benefit analysis and medical ethics.
• The cost-benefit analysis of a coronary care unit.
• Congenital vertebral anomalies: aetiology and relationship to spina bifida cystica.
• Cost-benefit analysis of patients treated at a rheumatism centre.